A factory owns the plant that compounds and fills your product. A trading company buys from that plant and resells the goods to you under its own name, taking title and a margin. A sourcing agent finds and manages suppliers for a fee and never owns the goods at all. All three are legitimate, and each is the right answer for some brands — but only one of them can hand you the manufacturing-site details that your safety file, your facility registration and your recall plan depend on. Before you pay a deposit, establish which of the three you are dealing with, and get the actual manufacturing site named in the supply agreement.
Key takeaways
- “Manufacturer” is a job, not a job title. Plenty of companies that call themselves manufacturers compound nothing and fill nothing. The question is not what is printed on the quotation — it is which legal entity operates the vessel your bulk is made in and the line it is filled on.
- The regulatory file is where the truth comes out. Your safety documentation, and in the United States your facility registration, both point at a physical manufacturing site. A supplier who will not name that site is telling you something about the relationship before the first purchase order.
- A trading company is not a fraud — a hidden one is a risk. Resellers add real value when they aggregate low volumes across several vendors. The damage comes from not knowing you are buying through one, because then you cannot see who to audit, who to hold liable, or who to call when a batch goes wrong.
- Ask for the things only a factory can produce. A GMP certificate whose site address matches the invoicing entity, an MOQ derived from vessel size rather than a round retail number, and an unscheduled video walk of the filling room are the three cheapest tests you can run.
- Going direct is not automatically cheaper. Removing an intermediary transfers their work to you — component chasing, incoming QC, translation, consolidation and credit. Price the work, not just the margin.
What is the difference between a factory, a trading company and a sourcing agent?
The three models differ on one axis that decides almost everything else: who owns the production assets, and who owns the goods. A factory owns or leases the plant and makes the product. A trading company owns the goods for a period — it buys from the factory and sells to you, so it is your legal seller and its name is on the commercial invoice. A sourcing agent never owns the goods; it works for a fee or commission and your contract of sale sits with the factory behind it. Everything you will argue about later — who holds the formula, who answers a deviation report, who is named in your product file — follows from that one distinction.
The complication is that in cosmetics the word “manufacturer” hides a second split. Making a skincare product involves compounding the bulk in a jacketed vessel and then filling it into primary packaging, and those are frequently different sites and occasionally different companies. A filling house with no compounding capability will still describe itself as a manufacturer, quite reasonably, because filling is manufacturing. But if the bulk is made elsewhere, the specification, the stability data and the raw-material traceability you care about live at a site you have not been shown. This is a different question from the OEM, ODM and private-label distinction, which describes how much of the development work a partner does rather than who owns the plant — our explainer on the difference between OEM, ODM and private label covers that axis, and it is worth reading alongside this one because a company can sit anywhere on both.
A fourth arrangement muddies the picture further: many genuine factories operate an affiliated export or trading entity, often for tax, foreign-exchange or licensing reasons. Your quotation comes from “XYZ International Trading Co. Ltd” while production happens at “XYZ Cosmetics Manufacturing Co. Ltd” down the road, under common ownership. That is normal and usually harmless — but from the outside it is indistinguishable from an unrelated reseller unless you ask, and the two situations carry very different risk.
| Model | Who owns the plant | Who owns the goods | What you can normally verify | The objection you should expect |
|---|---|---|---|---|
| Direct factory | The entity you contract with | Factory sells to you | Site address on the GMP certificate, business-licence scope, batch records, a live walk of the compounding and filling rooms | “Our MOQ is higher because we run full vessels” — usually true, and the honest version of the trade-off |
| Factory’s own export or trading arm | An affiliate under common ownership | The trading arm sells to you | Everything above, plus the ownership link between the two entities | “We invoice through our trading company for export” — fine, but ask for evidence the two are related |
| Independent trading company | Nobody — it buys from one or more plants | It buys, then resells to you | Its own trading licence and QC process; factory identity only if it chooses to disclose | “We protect our supplier relationships” — understandable commercially, but it caps what you can put in a product file |
| Sourcing agent or buying office | Nobody | Never takes title — you buy from the factory | The factory directly, because the agent introduces you to it | “Our commission is paid by the supplier” — the answer that tells you whose interests are being represented |
| Full-service brand-side OEM partner | Sometimes its own, sometimes contracted | Usually sells to you | Depends entirely on the arrangement — ask which of the four rows above actually applies | “We handle everything” — a service description, not an answer about ownership |
None of these rows is disqualifying. The point of the table is that you should be able to say, in one sentence and without hedging, which one your supplier is. If you cannot, that gap is itself the finding. Our comparison of running a full-service OEM against sourcing every element yourself looks at the same decision from the workload side.
Why does it matter who you are actually contracting with?
It matters because four things you are legally or commercially responsible for all resolve to a physical address, and an intermediary can obscure that address without ever telling you an untruth.
Your safety file needs the manufacturing method. In the European Union and the United Kingdom, the product information file behind every cosmetic includes a description of the manufacturing method and a statement of compliance with good manufacturing practice — the framework is set out on the European Commission’s cosmetics legislation portal and, for Great Britain, in the Cosmetic Products Enforcement Regulations 2013. Those are not documents a reseller can write on a factory’s behalf. If you have never been told where the bulk is compounded, your cosmetic product safety report rests on a supplier declaration rather than on evidence you can trace.
United States market entry names the facility explicitly. Under the Modernization of Cosmetics Regulation Act, facilities that manufacture or process cosmetic products for the US market must register with the FDA, and each product must be listed by its responsible person — see the FDA’s pages on MoCRA and on registration and listing of cosmetic product facilities and products. A trading company cannot register a facility it does not operate. If your intermediary is vague about which registration attaches to your product, you have a market-access problem rather than a paperwork preference. The sequencing for entering several markets at once is covered in our guide to expanding a beauty brand into the EU, UK and US.
Recalls run on batch records held at the plant. A withdrawal is an exercise in narrowing: which vessel, which raw-material lot, which filling shift, which pallets shipped where. Those records sit with whoever made the goods, and your right to call for them has to be written into an agreement with that party, or with someone who can compel them. Buying through an undisclosed reseller inserts a company with no records and no obligation between you and the only people who can answer the question. The underlying mechanics are set out in our explainer on shelf life, PAO and batch codes, and US enforcement expectations are described on the FDA’s cosmetics compliance and enforcement pages.
Your formula can end up owned by the middle. When a trading company commissions development on your behalf, the brief, the lab records and often the confidentiality agreement all sit between you and the chemist. Change intermediary and you may find the formula does not travel with you — not because anyone stole it, but because you were never a party to the document that would have said it was yours. That is a contract failure with a cheap fix, described in our guide to protecting your formula and IP with an OEM manufacturer.
There is a quieter failure mode as well. An intermediary who sources from more than one plant can, in perfect good faith, move your reorder to a second factory when the first is full. The formula is nominally the same; the vessel geometry, the homogeniser, the raw-material suppliers and the operators are not. Brands usually discover this through a texture or shade complaint several thousand units into a shipment, which is a slow and expensive way to learn who your manufacturer is.
How can you tell a factory from a trading company before you place an order?
You can usually settle it inside a week and at no cost, because a real manufacturer produces a specific class of document and a specific class of answer that a reseller has to go away and fetch. The tell is rarely a refusal — it is latency and vagueness on questions a plant answers instantly.
| Test | What to ask for | What a genuine manufacturer produces | What a reseller tends to produce instead |
|---|---|---|---|
| Certificate address match | The ISO 22716 or GMP certificate, plus the entity name and address that will appear on your invoice | A certificate whose site address is the plant, and an explanation if the invoicing entity differs | A certificate belonging to a third company, or an image with the address cropped out |
| Licence scope | The business licence or company registration, and its stated scope of business | A scope that includes manufacturing of cosmetics at a named site | A scope covering trade, import and export, or wholesale, with no production activity listed |
| Unscheduled video walk | A live video call, today, from the compounding room to the filling line | Someone walks the floor with a phone at short notice and can point at the vessel your batch would run in | A pre-recorded corporate video, a visit offered “next month”, or a slide deck of stock photography |
| MOQ arithmetic | Why the minimum order quantity is that particular number | A number derived from vessel capacity and fill weight — a 500 kg batch at 50 g fills roughly 9,500 saleable units after losses; at 250 g it fills roughly 1,900 | A round retail number — 1,000, 3,000, 5,000 — that stays the same regardless of fill size |
| Technical latency | A formulation question with a real constraint: raise the viscosity without adding a carbomer, or move to a preservative system acceptable in both the EU and Japan | An answer or a considered counter-question within a day, from someone who talks about the base rather than the price | Two to four days of silence, then a general reply that avoids the mechanism |
| Change pricing | The cost impact of one specific change — a different surfactant, a heavier fill, a second shade | A priced answer with a reason attached, because the plant knows its own material and changeover costs | A flat “no problem, same price”, or a long delay while the number is obtained elsewhere |
| Naming the site in the contract | A clause fixing the manufacturing site, with written notice required before any change | Agreement, sometimes with a carve-out for a named affiliate plant | Resistance framed as confidentiality, or agreement to a clause that names only the seller |
Two of these deserve emphasis because they are the hardest to fake. The first is the MOQ arithmetic. Batch minimums in cosmetics come from physics — a mixing vessel has a minimum working volume below which the homogeniser cannot shear properly — so a factory’s minimum moves when your fill size moves. A quoted MOQ that is identical for a 30 ml serum and a 250 ml lotion is a commercial policy, not a production constraint. That distinction also changes how you negotiate; our piece on mistakes to avoid when negotiating MOQ works through what is genuinely movable.
The second is the sample. Ask for a bench sample with one deliberate modification to the standard base — slightly lower fragrance, a different chelating agent, a texture change — and watch how the request is handled. A plant treats it as lab work and gives you a date. An intermediary treats it as a purchase and gives you a price. Our walkthrough of ordering a sample batch from a private-label factory sets out what a normal sequence looks like, and our note on GMP against ISO 22716 explains what the certificate you are address-matching actually certifies.
One caution: no single test is conclusive. Large, competent factories sometimes have weak English-language sales teams and slow replies. Good trading companies sometimes employ technically strong staff who handle formulation questions well. Read the pattern across all seven rows rather than disqualifying a supplier on one.
Where does the margin sit, and what does each model actually cost you?
Every model costs you something; they differ in whether the cost appears in the unit price or in your own calendar. A trading company’s margin is embedded in the price you are quoted and is usually invisible. An agent’s fee is explicit but may be paid by the other side. Going direct removes both and hands you the coordination work the intermediary was doing — real work with a real cost, even when it never appears on an invoice.
| Cost line | Direct factory | Through a trading company | Through a sourcing agent |
|---|---|---|---|
| Intermediary margin | None | Embedded in the unit price; commonly around 8–20% of goods value in private-label projects, and invisible unless disclosed | Explicit fee or commission, commonly 3–8% of order value, sometimes a retainer |
| Who chases components | You, or the factory if the deal is genuinely turnkey | The intermediary, across multiple vendors | The agent, on your instruction |
| Incoming quality control | Yours to arrange or to buy from a third party | Usually included, to the intermediary’s standard rather than to yours | Often the agent’s main deliverable and the strongest reason to use one |
| Consolidation and freight | One factory, one shipment — simple only if the factory really is turnkey | Consolidated across vendors into one shipment and one invoice | Arranged for you; you remain the buyer of record |
| Credit and payment risk | Your deposit sits with the factory | Your deposit sits with the intermediary, which may extend you terms it does not itself receive | You pay the factory directly; the agent’s fee is separate |
| Visibility into production | Full, if you ask for it | Filtered through the seller | Full, since you hold the factory relationship |
| Your own time per order | Highest — several vendor relationships to run in another timezone | Lowest — one counterparty, one purchase order | Low to moderate, and it falls as your team learns the market |
The percentage ranges above are ordinary commercial practice observed in private-label cosmetics projects, not surveyed data, and they vary widely by category, order size and region. Treat them as an order of magnitude for a conversation, not a benchmark for a negotiation. What matters more is that the margin is knowable: an intermediary willing to state its markup, or to move to an open-book fee, is a different proposition from one whose quotation is simply a number.
Two adjacent points are easy to get wrong. First, a lower factory-gate price does not automatically become a lower landed cost, because duties, freight terms and payment structure move independently — the ICC Incoterms 2020 rules decide who carries which leg and which risk, and the entity named on the commercial invoice affects your customs position, as US importers can see in CBP’s importer guidance and in classification via HS codes. Our guide to payment terms and deposits in cosmetics OEM works through the deposit exposure this creates, and reading a manufacturer’s quotation shows where an intermediary margin normally hides. Second, the quoted unit price is only one input to your retail price; the full stack is set out in our piece on pricing strategies for private-label beauty products.
When is a trading company or an agent actually the right choice?
Often — and pretending otherwise is how first-time founders end up with three months of unpaid logistics work. Buying direct is a capability, not a virtue, and it earns its keep only once your volumes and your team can absorb what the intermediary was absorbing for you.
A trading company earns its margin honestly in four situations. When your order sits below a factory’s minimum and the reseller can aggregate your volume with other buyers, it is selling you access you could not otherwise buy. When your product needs components from several vendors — bottle, pump, carton, decoration — and none of them will deal with a small buyer, consolidation is genuine value. When you have no language or timezone coverage, a counterparty who does removes a whole class of error. And when it extends payment terms it does not itself receive, it is financing your working capital, which has a price and is worth paying if the alternative is a full deposit against a batch you have not seen.
A sourcing agent earns its fee differently: it is buying you eyes on the ground. Pre-shipment inspection, a physical presence during your first production run, and someone who can walk into the plant when a shipment is late are worth a commission a purely remote brand cannot replicate. The critical question is whose payroll the agent is on. An agent paid by the supplier is a sales channel with a different name; an agent paid by you, on a fee you can see, is an adviser. Ask directly, in writing, and ask whether they take any rebate from the factory.
Conversely, buying direct starts to make sense when your volumes clear the factory’s natural minimums with room to spare, when you have someone who can read a specification and a certificate of analysis, when you are placing repeat orders of a stable formula rather than developing something new each quarter, and when your regulatory footprint has grown to the point where a documented chain to the manufacturing site is no longer optional. The geographic dimension of the same decision — whether the plant should be near you at all — is covered in our comparison of local against overseas cosmetics manufacturing.
It is also perfectly reasonable to run a hybrid: buy bulk and filling direct from a named factory, and keep an agent for component sourcing and inspection. What is not reasonable is not knowing which arrangement you are in.
What should you ask, and what should the contract say?
Once you know which model you are in, the protections come down to a short list of questions and a handful of clauses. Ask these before the deposit, in writing, and keep the replies:
- Which legal entity manufactures the product, and at what address? If it differs from the entity invoicing me, what is the relationship between them?
- Is the bulk compounded and filled at the same site? If not, name both, and say which one holds the master batch records.
- Which certificate covers that site, and may I see it with the address visible?
- If my product will be sold in the United States, which registered facility will it be attributed to?
- Do you buy from more than one plant for this product type? Under what circumstances would my reorder move, and would you tell me before it did?
- Who owns the formula developed for this project — me, you, or the plant — and which document says so?
- What is your margin or fee on this order, and does any part of your compensation come from the supplier?
- Will you accept a clause naming the manufacturing site, with written notice before any change?
The corresponding contract points are equally short. Name the manufacturing site and require notice before it changes. State who owns the formula and the development records, and say what happens to them if the relationship ends. Give yourself a right of access — yours or a third-party inspector’s — to the site during production. Fix retention periods for batch records and retention samples, and give yourself a right to call for both. And require the seller to pass any regulatory documentation obligation through to whoever actually holds the data. Worked wording for several of these appears in our collection of OEM cosmetics contract examples, and the document list you should be requesting in parallel is in our checklist of documents to request from a cosmetics manufacturer.
Red flags, in rough order of how much they should worry you: a refusal to name the manufacturing site under any confidentiality arrangement; a certificate whose address does not match anything else in the file; an MOQ that does not move with fill size; a deposit requested to a personal account or to an entity not named on the quotation; technical answers that arrive several days late and avoid mechanisms; and a promise that any change is free. Any one of these is survivable. Three together describe a counterparty who is passing your questions to someone else and hoping you do not notice. When you are ready to build a shortlist to run these tests against, our directory of OEM and ODM cosmetics manufacturers is a starting point, and our verification checklist covers the wider screen.
Frequently asked questions
Is it always better to buy direct from the factory?
No. Direct buying removes an intermediary’s margin and gives you a documented chain to the manufacturing site, but it also transfers that intermediary’s work to you: component sourcing across several vendors, incoming inspection, consolidation, translation and timezone coverage. Below a certain volume you may also fail to reach a factory’s minimum order quantity at all. Direct is the right answer when your volumes clear the plant’s natural batch minimums, your formula is stable, and someone on your side can read a specification and a certificate of analysis. Until then, a disclosed intermediary with a named factory behind it is usually the better trade.
How can I tell if a supplier on a B2B marketplace is a real factory?
Match documents to addresses rather than reading profile badges. Ask for the GMP or ISO 22716 certificate with the site address visible, the business licence showing manufacturing in its scope, and the entity name that will appear on the invoice, then check whether all three point to the same place. Follow up with a live, unscheduled video call from the compounding room to the filling line. Marketplace verification badges generally confirm that a company exists and has been identity-checked, not that it operates a plant.
What happens to my formula if I stop working with a trading company?
It depends entirely on who signed what. If the development agreement and confidentiality terms were between the trading company and the plant, you may have no contractual claim to the formula even though you paid for its development, and the plant may be barred from supplying you directly. Fix this before development starts by being a named party to the development and confidentiality documents, or by requiring assignment of the formula and lab records to you on payment. Ask the question in writing at quotation stage; the answer is also a useful signal about the relationship.
Does a sourcing agent charging the supplier instead of me cost me anything?
Yes, in two ways. The commission is still in your price, simply routed through the factory, and an agent paid by the supplier has a financial interest in the order closing rather than in the supplier being the right one. That does not make supplier-paid agents useless, but it changes what their advice is worth. Ask who pays them, whether they receive rebates or volume bonuses from any factory, and consider paying a transparent fee yourself for genuinely independent selection and inspection.
Can a trading company be named as the manufacturer in my regulatory documents?
Generally not for the manufacturing information itself. Safety documentation in the EU and UK includes a description of the manufacturing method and a GMP compliance statement relating to the site where the product is made, and US facility registration under MoCRA attaches to the facility that manufactures or processes the product. A seller that does not operate a plant cannot supply those facts from its own operations. It can pass them through from the factory — a perfectly workable arrangement — but you should see the underlying documents rather than a summary written by the intermediary.
Sources and limitations
Sources. Requirements for the product information file, the manufacturing-method description and the GMP compliance statement in the EU are set out through the European Commission’s cosmetics legislation portal, with ingredient nomenclature in CosIng and scientific opinions from the Scientific Committee on Consumer Safety; notification runs through the Cosmetic Products Notification Portal. Great Britain enforces equivalent duties under the Cosmetic Products Enforcement Regulations 2013. In the United States, facility registration and product listing obligations are described by the FDA under MoCRA and in its registration and listing guidance, with labelling in the Cosmetics Labeling Guide and enforcement on the compliance and enforcement pages. ASEAN product information file expectations are summarised by Singapore’s Health Sciences Authority under the ASEAN Cosmetic Directive. Delivery, risk and cost allocation follow the ICC Incoterms rules; customs classification and importer responsibilities are covered by HS codes and CBP importer guidance. Good manufacturing practice for cosmetics is described by ISO 22716, the standard against which most of the certificates discussed here are issued.
Limitations. The margin and commission ranges, response times and verification tests described here are ordinary commercial practice observed in private-label cosmetics projects, not surveyed data or regulatory requirements, and they vary substantially by category, order size, region and supplier. The MOQ arithmetic is illustrative: real yields depend on vessel geometry, viscosity, transfer losses and fill tolerance. We did not audit any manufacturer, trading company or sourcing agent in preparing this article, and nothing here is an assessment of any named or unnamed company. Regulatory requirements differ by market and product type and change over time. Confirm your own position against the primary sources linked above, or with a qualified regulatory adviser in your destination market, before signing a supply agreement. Last reviewed 4 September 2026.
This article is general information for brand owners and sourcing teams, not legal, regulatory or commercial advice. Supplier structures, contractual protections and market-access obligations differ by jurisdiction, product category and business model and change over time — confirm your own position with a qualified adviser before committing to a supplier or paying a deposit.